Should I buy or sell INDEGENE?

The average broker rating on INDEGENE is Sell. The breakup of analyst rating is given below - 0 analysts have given a strong sell rating 0 analysts have given a sell rating 0 analysts have given a hold rating 0 analysts have given a buy rating 0 analysts have given a strong buy rating

Is INDEGENE a good stock to invest in?

INDEGENE can be analyzed on the following key metrics - TTM P/E: - Sector P/E: 34.97 Dividend Yield: - D/E ratio: -

INDEGENE Share Price

Powered by

700.00 +19.10 (2.81%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 669.65

Today’s High 711.3

52 Week Low 468.9

52 Week High 736.6

Key Metrics

Sector P/E 34.97
Open Price 682.95
Prev Close 680.9

View All Metrics

INDEGENE Analysis

Risk Meter

170% Low risk
170% Moderate risk
170% Balanced Risk
170% High risk
170% Extreme risk

Recos

Strong Sell
Sell
Hold
Buy
Strong Buy

INDEGENE News

Stock market today: The Nifty 50 index has a support at 25,650 mark, and the 50-stock index faces a resistance at 26,000 points, estimates Vaishali Parekh of Prabhudas Lilladher. (Photo: Courtesy Prabhudas Lilladher)

Premium

Buy or sell: Vaishali Parekh recommends three stocks to buy today — 23 September

2 min read . 24 Sep 2024

Down 15% from debut price, JPMorgan is neutral on Indegene; awaits better entry point

Premium

Down 15% from debut, JPMorgan is neutral on Indegene. Here's why

4 min read . 28 Aug 2024

May 2024 saw 5 IPOs raising ₹9,606 crore, the highest in 8 months. Offers for Sale category accounted for 64 percent of total fundraising. TBO Tek had best debut performance at 55 percent premium, followed by Indegene at 45 percent.

Premium

May 2024 IPO market sees ₹9,606 cr raised by 5 firms, no discounts on listing

3 min read . 10 Jun 2024

Market analysts expect primary issuance activity in 2024-25 to cross ₹1.5 trillion. (PTI)

Premium

IPO rush sets up India’s equity market for another record year

5 min read . 21 May 2024

View More News

INDEGENE Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
2589.6

Selling/ General/ Admin Expenses Total
1651.6

Depreciation/ Amortization
76.1

Other Operating Expenses Total
432.6

Total Operating Expense
2157.9

Operating Income
431.7

Net Income Before Taxes
458.6

Net Income
336.7

Diluted Normalized EPS
14.99

Period
2023

Total Revenue
2306.13

Selling/ General/ Admin Expenses Total
1557.48

Depreciation/ Amortization
59.81

Other Operating Expenses Total
352.43

Total Operating Expense
1969.72

Operating Income
336.41

Net Income Before Taxes
363.05

Net Income
266.1

Diluted Normalized EPS
11.12

Period
2022

Total Revenue
1664.61

Selling/ General/ Admin Expenses Total
1073.03

Depreciation/ Amortization
33.45

Other Operating Expenses Total
304.65

Total Operating Expense
1458.04

Operating Income
206.57

Net Income Before Taxes
226.5

Net Income
164.76

Diluted Normalized EPS
8.3

Period
2021

Total Revenue
966.27

Selling/ General/ Admin Expenses Total
563.92

Depreciation/ Amortization
25.55

Other Operating Expenses Total
171.82

Total Operating Expense
750.26

Operating Income
216.01

Net Income Before Taxes
231.46

Net Income
149.4

Diluted Normalized EPS
7.39

Period
2020

Total Revenue
642.93

Selling/ General/ Admin Expenses Total
413.97

Depreciation/ Amortization
19.34

Other Operating Expenses Total
85.31

Total Operating Expense
561.75

Operating Income
81.18

Net Income Before Taxes
75.8

Net Income
-6.3

Diluted Normalized EPS
3.51

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

INDEGENE Technical

Moving Average SMA

5 Day692.02
10 Day682.15
20 Day684.3

50 Day635.56
100 Day600.64
300 Day551.74

INDEGENE Peers

Price
Ratio

INDEGENE Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

01-Aug-24
Quarterly Results

29-May-24
Audited Results

View All

INDEGENE SUMMARY

INDEGENE is trading 2.81% upper at Rs 700.00 as compared to its last closing price. INDEGENE has been trading in the price range of 711.3 & 669.65.

There are 3 analysts who have initiated coverage on INDEGENE. There are 0 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.

The company posted a net profit of 87.7 Crores in its last quarter.

INDEGENE has a 100% public holding.

FAQs about INDEGENE

INDEGENE is trading at 700.00 as on 18 Oct, 2024 3:48:16 PM. This is 2.81% upper as compared to its previous closing price of 680.9

The market capitalization of INDEGENE is - as on 18 Oct, 2024 3:48:16 PM.

The average broker rating on INDEGENE is Sell. The breakup of analyst rating is given below -

0 analysts have given a strong sell rating
0 analysts have given a sell rating
0 analysts have given a hold rating
0 analysts have given a buy rating
0 analysts have given a strong buy rating

The 52 wk high for INDEGENE is 736.6 whereas the 52 wk low is 468.9

INDEGENE can be analyzed on the following key metrics -

TTM P/E: -
Sector P/E: 34.97
Dividend Yield: -
D/E ratio: -

INDEGENE reported a net profit of 336.7 Cr in 2024.

INDEGENE Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

INDEGENE Share Price

Price Range

Price Range

Key Metrics

INDEGENE Analysis

INDEGENE News

Buy or sell: Vaishali Parekh recommends three stocks to buy today — 23 September

Down 15% from debut, JPMorgan is neutral on Indegene. Here's why

May 2024 IPO market sees ₹9,606 cr raised by 5 firms, no discounts on listing

IPO rush sets up India’s equity market for another record year

INDEGENE Financials

Forecast

Forecast

Forecast

INDEGENE Technical

INDEGENE Peers

INDEGENE Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

INDEGENE SUMMARY

FAQs about INDEGENE

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue